Back

Role of novel biomarkers to improve risk stratification in aortic stenosis: focus on plasma ACE2 activity

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Prognosis in aortic stenosis Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Jay Ramchand

Cleveland Clinic Foundation, Cleveland (United States of America)

9 More presentations in this session

Presentation thumbnail
Aortic valve resistance risk-stratifies low gradient aortic stenosis
Doctor H. Nishikawa (Kawasaki, JP)
Abstract Slides
Presentation thumbnail
Impact of estimated left atrial volume on prognosis in patients with initially asymptomatic mild to moderate aortic stenosis
Associate Professor M. Losi (Naples, IT)
Abstract Slides
Presentation thumbnail
COPD in symptomatic aortic stenosis: the importance of correct assessment for defining prognosis
Doctor M. Rigolli (San Diego, US)
Abstract
Presentation thumbnail
Extracellular volume by cardiac magnetic resonance predicts outcomes in patients with severe aortic stenosis who underwent aortic valve replacement
Professor S. Park (Seoul, KR)
Presentation thumbnail
Transcatheter and surgical aortic bioprosthetic valve leaflet thrombosis defined by computed tomography is associated with cerebrovascular events: contemporary meta-analysis of 8 observational studies
Doctor H. Rashid (Melbourne, AU)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Prognosis in aortic stenosis

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources